526 - 550 of 60.877
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Novo Nordisk Call 405,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,70x
- Analysis
- Novo Nordisk Call 275,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,07x
- Analysis
- Novo Nordisk Call 535,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,25x
- Analysis
- Novo Nordisk Call 375,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,59x
- Analysis
- Novo Nordisk Call 485,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,28x
- Analysis
- Novo Nordisk Call 305,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,41x
- Analysis
- Novo Nordisk Call 315,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,51x
- Analysis
- Novo Nordisk Call 515,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,17x
- Analysis
- Novo Nordisk Call 295,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 3,29x
- Analysis
- Novo Nordisk Call 455,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,10x
- Analysis
- Novo Nordisk Call 315,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,86x
- Analysis
- Novo Nordisk Call 415,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,82x
- Analysis
- Novo Nordisk Call 525,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,42x
- Analysis
- Novo Nordisk Call 425,00 19 Jun 2026
- Goldman Sachs
- 19.06.26
- 4,42x
- Analysis
- Novo Nordisk Call 505,00 19 Sep 2025
- Goldman Sachs
- 19.09.25
- 8,36x
- Analysis
- Novo Nordisk Call 445,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,95x
- Analysis
- Novo Nordisk Call 505,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,15x
- Analysis
- Novo Nordisk Call 365,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,51x
- Analysis
- Novo Nordisk Call 335,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,14x
- Analysis
- Novo Nordisk Call 345,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 4,27x
- Analysis
- Novo Nordisk Call 305,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,68x
- Analysis
- Novo Nordisk Call 325,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,95x
- Analysis
- Novo Nordisk Call 545,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 5,50x
- Analysis
- Novo Nordisk Call 295,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,58x
- Analysis
- Novo Nordisk Call 285,00 20 Mar 2026
- Goldman Sachs
- 20.03.26
- 3,41x
- Analysis